SCHEMBL7874871

SCHEMBL7874871

c1ccc(C2CCN(CC3CN(Cc4cccc5ccccc45)CC3c3ccsc3)CC2)cc1

nearest known ligand 0.60

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
CCR5 P51681 16/20 0.60
ACHE P22303 1/20 0.43
MEN1 O00255 1/20 0.41
KMT2A Q03164 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7869741 0.93 CCR5 (0.52) CCR5ACHEMEN1KMT2A
SCHEMBL7869911 0.93 CCR5 (0.52) CCR5ACHEMEN1KMT2A
SCHEMBL7838439 0.90 CCR5 (0.69) CCR5ACHE
SCHEMBL7868394 0.85 CCR5 (0.78) CCR5MEN1KMT2A
SCHEMBL7869960 0.83 CCR5 (0.65) CCR5ACHEMEN1KMT2A
SCHEMBL7871883 0.80 SLC6A4 (0.42) CCR5
SCHEMBL7870825 0.80 CCR5 (0.82) CCR5
SCHEMBL7874833 0.80 CCR5 (0.82) CCR5
SCHEMBL7870830 0.80 CCR5 (0.82) CCR5
SCHEMBL7872050 0.79 CCR5 (0.54) CCR5MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6303593-B1 FOR THERAPY HUMAN IMMUNODEFICIENCY VIRUS INFECTION, AQUIRED IMMUNODEFICIENCY SYNDROME (AIDS), INFLAMMATORY AND IMMUNOREGULATORY DISORDER OR DISEASE, ASTHMA, ALLERGIC RHINITIS, DERMATITIS, CONJUNCTIVITIS, ATHEROSCLEROSIS MERCK & CO., INC. 2001-10-16 US claimed
US-6303593-B1 FOR THERAPY HUMAN IMMUNODEFICIENCY VIRUS INFECTION, AQUIRED IMMUNODEFICIENCY SYNDROME (AIDS), INFLAMMATORY AND IMMUNOREGULATORY DISORDER OR DISEASE, ASTHMA, ALLERGIC RHINITIS, DERMATITIS, CONJUNCTIVITIS, ATHEROSCLEROSIS MERCK & CO., INC. 2001-10-16 US disclosed